V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20222654 | 20084517 | 1.67 | 99 | Neo-adjuvant (N) | 2018-07-03 | 2018-07-25 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | CARBOPLATIN + PACLITAXEL + RT | 100929539 |
| 20222660 | 20084518 | 1.7 | 80.65 | Palliative (P) | null | 2016-12-30 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100402086 |
| 20222665 | 20084519 | 0 | 0 | Palliative (P) | 2017-11-12 | 2017-11-12 | CARBOPLATIN + PACLITAXEL + RT | 2 | N | CARBOPLATIN + PACLITAXEL + RT | 100221169 |
| 20222668 | 20084520 | 1.66 | 69 | null | 2019-08-08 | 2019-08-10 | Enzalutamide | 02 | null | CISPLATIN | 101706080 |
| 20222684 | 20084521 | 1.62 | null | Palliative (P) | 2018-09-22 | 2018-10-06 | Trastuzumab | 02 | N | TRASTUZUMAB | 101426317 |
| 20222685 | 20084522 | 1.44 | 93 | Palliative (P) | null | 2019-11-22 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100294088 |
| 20222690 | 20084523 | 1.57 | 91.3 | Curative (C) | 2021-03-16 | 2021-03-16 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101327387 |
| 20222692 | 20084524 | 1.76 | 66.3 | Palliative (P) | 2018-05-05 | 2018-05-05 | Enzalutamide | 2 | N | SCALOP-2 TRIAL | 101491074 |
| 20222693 | 20084525 | 1.64 | 115.5 | null | 2016-04-06 | 2016-04-06 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100505034 |
| 20222699 | 20084526 | 1.76 | 114 | Palliative (P) | 2019-02-19 | 2019-02-19 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100401037 |
| 20222704 | 20084527 | 1.67 | 74.1 | Palliative (P) | 2018-07-29 | 2018-08-12 | Enzalutamide | N | N | OCTREOTIDE | 101569448 |
| 20222705 | 20084528 | 1.74 | null | Curative (C) | 2016-09-20 | 2016-09-20 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100532657 |
| 20222712 | 20084529 | 1.64 | 59 | Curative (C) | 2019-08-04 | 2019-09-07 | OCTREOTIDE | 02 | N | OCTREOTIDE | 101653824 |
| 20222716 | 20084530 | 1.46 | 50.8 | Curative (C) | 2019-08-24 | 2019-08-24 | Carboplatin AUC 2 - 5 | 02 | Y | ENZALUTAMIDE | 101524838 |
| 20222720 | 20084531 | 1.82 | 75.95 | Curative (C) | 2016-05-09 | 2016-05-10 | SCALOP-2 Trial | 01 | N | SCALOP-2 TRIAL | 100618403 |
| 20222722 | 20084532 | 1.62 | 80.3 | Palliative (P) | 2019-03-02 | 2019-04-02 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100303615 |
| 20222725 | 20084533 | 1.59 | 83.4 | Disease modification (D) | 2017-05-20 | 2017-05-20 | Capecitabine + Cisplatin + RT | 2 | N | OCTREOTIDE | 100500162 |
| 20222736 | 20084534 | 1.6 | 69 | Not known (9) | 2017-07-06 | 2017-08-31 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101248611 |
| 20222745 | 20084535 | 1.76 | null | null | 2019-12-03 | 2020-01-04 | Carboplatin AUC 2 - 5 | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101412535 |
| 20222746 | 20084536 | 1.6 | 58.5 | Palliative (P) | 2017-09-20 | 2017-09-20 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN + GEMCITABINE | 100538492 |
| 20222750 | 20084537 | 1.69 | 61.4 | null | 2019-07-11 | 2019-07-12 | Enzalutamide | 02 | null | TRASTUZUMAB | 100594514 |
| 20222751 | 20084538 | null | 56.7 | null | 2016-01-12 | 2016-02-02 | Enzalutamide | 02 | null | OCTREOTIDE | 101048077 |
| 20222752 | 20084539 | null | 70 | Neo-adjuvant (N) | 2016-06-16 | 2016-07-04 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101491789 |
| 20222757 | 20084540 | 1.68 | 71 | null | 2018-08-04 | 2018-08-18 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100702111 |
| 20222768 | 20084541 | 0 | null | Neo-adjuvant (N) | 2017-12-14 | 2017-12-14 | Enzalutamide | 02 | Y | SCALOP-2 TRIAL | 100771235 |
| 20222769 | 20084542 | 1.64 | 140.3 | Neo-adjuvant (N) | 2019-09-04 | 2019-09-09 | Enzalutamide | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100977983 |
| 20222776 | 20084543 | 1.61 | 51 | null | 2018-07-09 | 2018-07-16 | Enzalutamide | 02 | null | CISPLATIN | 100134353 |
| 20222779 | 20084544 | 1.76 | 76.9 | 03 | null | 2019-05-09 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100012040 |
| 20222781 | 20084545 | 1.64 | 72 | null | 2021-10-12 | 2021-10-12 | Enzalutamide | 02 | null | CAPECITABINE + TEMOZOLOMIDE | 100849439 |
| 20222782 | 20084546 | 1.76 | 64.4 | null | 2019-03-16 | 2019-03-16 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 100209995 |
| 20222787 | 20084547 | 1.51 | null | Curative (C) | 2017-06-19 | 2017-06-22 | Enzalutamide | 02 | Y | CAPECITABINE + CISPLATIN + RT | 101814759 |
| 20222788 | 20084548 | 1.59 | 91 | Adjuvant (A) | 2019-03-26 | 2019-03-26 | Enzalutamide | 02 | Y | CETUXIMAB | 100735794 |
| 20222790 | 20084549 | 1.66 | 80.7 | Palliative (P) | 2018-03-19 | 2018-03-22 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101031934 |
| 20222792 | 20084550 | 1.61 | null | Palliative (P) | 2020-03-31 | 2020-06-25 | Enzalutamide | N | N | CETUXIMAB + OXALIPLATIN + MDG | 101534306 |
| 20222795 | 20084551 | 1.6 | 58.5 | null | 2016-03-25 | 2016-04-12 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 100619029 |
| 20222799 | 20084552 | 1.82 | 81.15 | 03 | 2019-11-23 | 2019-12-05 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100053931 |
| 20222801 | 20084553 | 1.6 | 60.9 | Palliative (P) | 2015-07-06 | 2015-07-08 | Enzalutamide | 2 | N | OCTREOTIDE | 101611680 |
| 20222802 | 20084554 | 1.81 | 52 | Curative (C) | 2016-07-26 | 2016-08-09 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101227591 |
| 20222805 | 20084555 | 1.75 | 65.2 | Neo-adjuvant (N) | 2019-06-21 | 2019-06-26 | Enzalutamide | 02 | null | ECF | 100528377 |
| 20222809 | 20084556 | 1.73 | 99 | Neo-adjuvant (N) | 2017-12-19 | 2017-12-19 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101443413 |
| 20222810 | 20084557 | 1.56 | 66 | Curative (C) | 2018-11-23 | 2018-11-23 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101228755 |
| 20222811 | 20084558 | 1.74 | 169.3 | Adjuvant (A) | 2016-12-13 | 2016-12-16 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101581646 |
| 20222815 | 20084559 | 1.59 | 72.3 | Palliative (P) | null | 2018-09-03 | ATEZOLIZUMAB + BEVACIZUMAB | null | N | ATEZOLIZUMAB + BEVACIZUMAB | 100734728 |
| 20222819 | 20084560 | 1.76 | 115.5 | Palliative (P) | null | 2019-03-07 | Enzalutamide | 2 | N | OXALIPLATIN + RALTITREXED | 100020649 |
| 20222821 | 20084561 | 1.67 | 71.8 | null | 2017-03-25 | 2017-03-31 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101637198 |
| 20222823 | 20084562 | 1.78 | null | Curative (C) | 2016-05-08 | 2016-05-23 | ECF | N | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100913625 |
| 20222825 | 20084563 | 1.76 | 95.1 | Curative (C) | 2015-09-04 | 2015-09-10 | Enzalutamide | 02 | Y | CAPECITABINE + CISPLATIN + RT | 101454591 |
| 20222830 | 20084564 | 0 | 0 | Palliative (P) | 2018-05-27 | 2018-05-30 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101294353 |
| 20222841 | 20084565 | null | null | Curative (C) | 2019-09-25 | 2019-09-25 | Enzalutamide | 02 | N | CARBOPLATIN | 101217005 |
| 20222850 | 20084566 | 1.78 | 58.2 | Neo-adjuvant (N) | 2016-12-25 | 2017-03-24 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100367376 |